We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
hVIVO Plc | AQSE:HVO.GB | Aquis Stock Exchange | Ordinary Share | GB00B9275X97 |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
-0.50 | -2.44% | 20.00 | 19.00 | 21.00 | 20.00 | 19.5066 | 20.00 | 8,458 | 15:29:37 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
TIDMHVO
RNS Number : 4280W
hVIVO plc
11 December 2019
FORM 8 (OPD)
PUBLIC OPENING POSITION DISCLOSURE BY A PARTY TO AN OFFER
Rules 8.1 and 8.2 of the Takeover Code (the "Code")
1. KEY INFORMATION (a) Full name of discloser: hVIVO plc ("hVIVO") (b) Owner or controller of interests and short positions disclosed, if different from 1(a): n/a The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named. ---------------------- (c) Name of offeror/offeree in relation to whose relevant securities this form relates: hVIVO plc Use a separate form for each offeror/offeree ---------------------- (d) Is the discloser the offeror or the offeree? OFFEREE ---------------------- (e) Date position held: 06/12/2019 The latest practicable date prior to the disclosure ---------------------- (f) In addition to the company in 1(c) above, is the discloser making disclosures in respect YES - Open Orphan Plc of any other party to the offer? If it is a cash offer or possible cash offer, state "N/A" ---------------------- 2. POSITIONS OF THE PARTY TO THE OFFER MAKING THE DISCLOSURE
If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.
(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates
Class of relevant security: Interests Short positions ------------- ------------------ Number % Number % ------- ---- ----------- ----- (1) Relevant securities owned and/or controlled: Nil Nil Nil Nil ------- ---- ----------- ----- (2) Cash-settled derivatives: Nil Nil Nil Nil ------- ---- ----------- ----- (3) Stock-settled derivatives (including options) and agreements to purchase/sell: Nil Nil Nil Nil ------- ---- ----------- ----- Nil Nil Nil Nil TOTAL: ------- ---- ----------- -----
All interests and all short positions should be disclosed.
Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).
Details of any securities borrowing and lending positions or financial collateral arrangements should be disclosed on a Supplemental Form 8 (SBL).
(b) Rights to subscribe for new securities Class of relevant security in relation to which subscription right exists: Nil Details, including nature of the rights concerned and relevant percentages: Nil ---- 3. POSITIONS OF PERSONS ACTING IN CONCERT WITH THE PARTY TO THE OFFER MAKING THE DISCLOSURE Details of any interests, short positions and rights to subscribe (including directors' and other employee options) of any person acting in concert with the party to the offer making the disclosure: Interests of hVIVO Directors in hVIVO shares: Name No. of shares % Dr Trevor Phillips 44,776 0.05 -------------- ----- James Winschel 154,548 0.19 -------------- ----- Dr Mark Warne 5,677 0.01 -------------- ----- Interests of hVIVO Directors in options over hVIVO shares: Name No. of Grant date % vested Expiry Exercise options date price (p) Dr Trevor Phillips 850,000 20/12/17 nil 19/12/27 5p --------- ----------- --------- --------- ----------- Dr Trevor Nicholls 26,540 02/04/14 100 18/12/22 101.63p --------- ----------- --------- --------- -----------
Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).
Details of any securities borrowing and lending positions or financial collateral arrangements should be disclosed on a Supplemental Form 8 (SBL).
4. OTHER INFORMATION (a) Indemnity and other dealing arrangements Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the party to the offer making the disclosure or any person acting in concert with it: Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none" None (b) Agreements, arrangements or understandings relating to options or derivatives Details of any agreement, arrangement or understanding, formal or informal, between the party to the offer making the disclosure, or any person acting in concert with it, and any other person relating to: (i) the voting rights of any relevant securities under any option; or (ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced: If there are no such agreements, arrangements or understandings, state "none" None (c) Attachments
Are any Supplemental Forms attached?
Supplemental Form 8 (Open Positions) NO Supplemental Form 8 (SBL) NO --- Date of disclosure: 11/12/2019 Contact name: Anesh Patel (Interim Finance Director & Company Secretary) ----------------------------------------------------------- Telephone number: +44(0)207 148 1018 -----------------------------------------------------------
Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.
The Panel's Market Surveillance Unit is available for consultation in relation to the Code's disclosure requirements on +44 (0)20 7638 0129.
The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
END
FEEUROBRKOAUAAA
(END) Dow Jones Newswires
December 11, 2019 02:00 ET (07:00 GMT)
1 Year hVIVO Chart |
1 Month hVIVO Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions